Related Experiment Videos
[Radiosensitization by paclitaxel. The in-vivo results in paclitaxel-sensitive and -resistant tumors]
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status.
Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2011
On the use of HDR 60Co source with the MammoSite radiation therapy system.
Medical physics·2009
First dosimetric evaluation of deformable dose accumulation in human individuals.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Acute toxicity and patient-reported quality of life during daily online adaptive radiotherapy versus conventional IGRT for localized prostate cancer: a prospective parallel cohort study.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Centralization of MR image-guided adaptive brachytherapy for cervical cancer in Austria: feasibility and outcomes.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Impact of PET/CT imaging on target volume delineation and radiotherapy planning in patients with locally advanced esophageal cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Thirty-Two Years of Radiotherapy for T1 Anal Cancer: Patterns, Outcomes, and Side-effects at a Single Institution.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Re-irradiation in central lung cancer-a monocentric detailed analysis.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026